Form 8-K - Current report:
SEC Accession No. 0001213900-16-015528
Filing Date
2016-08-04
Accepted
2016-08-04 08:00:17
Documents
3
Period of Report
2016-08-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k080416_actiniumpharma.htm 8-K 15364
2 PRESS RELEASE f8k080416ex99i_actinium.htm EX-99.1 27629
3 GRAPHIC image_004.jpg GRAPHIC 12033
  Complete submission text file 0001213900-16-015528.txt   60896
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 161805819
SIC: 2834 Pharmaceutical Preparations